{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:50:13Z","timestamp":1768636213876,"version":"3.49.0"},"reference-count":18,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,20]]},"abstract":"<p><italic>Opportunities for strengthening surveillance of meningococcal disease exist between and within countries in Latin America. In August of 2015, a workshop was convened in the city of S\u00e3o Paulo, Brazil, to address the following objectives: 1) to review meningococcal disease burden and vaccine use in Latin America; 2) to evaluate the effectiveness of current meningococcal surveillance practices in the region; 3) to identify challenges to meningococcal surveillance in the region; and 4) to outline steps for strengthening meningococcal surveillance and disease control in the region. Based on the workshop\u2019s discussions, recommendations for strengthening surveillance and controlling meningococcal disease in Latin America focus on improving: a) laboratory capabilities for diagnostic testing; b) communication regarding epidemiologic- and laboratory-based analyses; c) communication during outbreaks; d) monitoring of long-term disease outcomes; e) knowledge of vaccines against serogroup B disease; and f) criteria for defining and controlling meningococcal outbreaks. Overall, improving surveillance will help guide strategies for meningococcal disease prevention and control in Latin America.<\/italic><\/p>","DOI":"10.26633\/rpsp.2017.118","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T19:56:29Z","timestamp":1519674989000},"page":"1","source":"Crossref","is-referenced-by-count":2,"title":["Knowing the scope of meningococcal disease in Latin America"],"prefix":"10.26633","volume":"41","author":[{"given":"Marco A. P.","family":"S\u00e1fadi","sequence":"additional","affiliation":[{"name":"Santa Casa de S\u00e3o Paulo School of Medical egy to prevent meningococcal disease. Sciences, S\u00e3o Paulo, Brazil. Send correspondence to: Marco A. P. S\u00e1fadi, masafadi@uol.com.br"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Valenzuela","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad de los Andes, Santiago, Chile."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Flavia","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Sabin Vaccine Institute, Washington, D.C., United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00facia Helena","family":"De Oliveira","sequence":"additional","affiliation":[{"name":"Pan American Health Organization, Washington, D.C., United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M","family":"Salisbury","sequence":"additional","affiliation":[{"name":"Centre on Global Health Security at Chatham House, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon Kim","family":"Andrus","sequence":"additional","affiliation":[{"name":"Sabin Vaccine Institute, Washington, D.C., United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11167","reference":[{"key":"ref1","unstructured":"1. World Health Organization. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec. 2011 Nov 18;86(47):521\u201339."},{"key":"ref2","unstructured":"2. World Health Organization. Epidemics of meningococcal disease. African meningitis belt, 2001. Wkly Epidemiol Rec. 2001 Sep 14;76(37):282\u20138."},{"key":"ref3","unstructured":"3. Centers for Disease Control and Prevention. Meningococcal disease: diagnosis& treatment. Available from: https:\/\/www.cdc.gov\/meningococcal\/about\/diagnosis-treatment.html Accessed 1 Feb 2017."},{"key":"ref4","unstructured":"4. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases: meningococcaldisease. Available from: http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/mening.html Accessed 1 Feb 2017."},{"key":"ref5","unstructured":"5. Quadros C, Harrison L, Ruiz Matus C, Safadi M, de Oliveira LH, Fukasawa L, et al. First Regional Meningococcal Symposium 2012 19\u201320 March Buenos Aires, Argentina Proceedings. Washington, D.C.: Pan American Health Organization, Sabin Vaccine Institute; 2014. Available from: http:\/\/www.sabin.org\/updates\/resources\/first-regional-meningococ-cal-symposium-proceedings Accessed 9 Jan 2017."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Hedari CP, Khinkarly RW, Dbaibo GS. Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease. Infect Drug Resist. 2014 Apr 3;7:85\u201399.","DOI":"10.2147\/IDR.S36243"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B, et al. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A. 1997 Jan 7; 94(1):271\u20136.","DOI":"10.1073\/pnas.94.1.271"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. S\u00e1fadi MA, McIntosh ED. Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies. Expert Rev Vaccines. 2011 Dec 1;10(12): 1717\u201330.","DOI":"10.1586\/erv.11.159"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Harrison LH, Pelton SI, Wilder-Smith A, Holst J, Safadi MA, Vazquez JA, et al. The Global Meningococcal Initiative: recommendationsfor reducing the global burdenof meningococcal disease. Vaccine. 2011 Apr 18;29(18):3363\u201371.","DOI":"10.1016\/j.vaccine.2011.02.058"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. S\u00e1fadi MA, Gonz\u00e1lez-Ayala S, J\u00e4kel A, Wieffer H, Moreno C, Vyse A. The epidemiologyof meningococcal disease in Latin America 1945\u20132010: an unpredictable- and changing landscape. Epidemiol Infect. 2013 Mar 1; 141(03): 447\u201358.","DOI":"10.1017\/S0950268812001689"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. D\u00edaz J, C\u00e1rcamo M, Seoane M, Pidal P, Cavada G, Puentes R, et al. Prevalence of meningococcal carriage in children and adolescents aged 10\u201319 years in Chile in 2013. J Infect Public Health. 2016 Jul Aug; 9(4):506\u201315.","DOI":"10.1016\/j.jiph.2015.12.011"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Araya P, Fern\u00e1ndez J, Canto Fuentes FD, Seoane M, Ibarz Pav\u00f3n A, Barra G, et al. Neisseria meningitidis ST-11 clonal complex,Chile, 2012. Emerg Infect Dis. 2015 February; 21(2): 339\u201341.","DOI":"10.3201\/eid2102.140746"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Araya P, D\u00edaz J, Seoane M, Fernandez J, Terrazas S, Canals A, et al. [Laboratory surveillance for invasive meningococcal disease in Chile, 2006\u20132012]. Rev Chilena Infectol. 2014 Aug;31(4):377\u201384.","DOI":"10.4067\/S0716-10182014000400001"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Valenzuela MT, Moreno G, Vaquero A, Seoane M, Hormazabal JC, Bertoglia MP, et al. [Emergence of W135 meningococcal serogroup in Chile during 2012]. Rev Med Chil. 2013 Aug;141(8):959\u201367.","DOI":"10.4067\/S0034-98872013000800001"},{"key":"ref15","unstructured":"15. S\u00e1fadi MA, Almeida RJ, Mimica MJ, Almeida FJ, Berezin EN. Epidemiology and clinical manifestations of meningococcaldisease in S\u00e3o Paulo. Paper presentedat: European Congress of Pediatric Infectious Diseases; 2-4 May 2007; Porto, Portugal."},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. S\u00e1fadi MA, O\u2019Ryan M, Bravo MT, Brandileone MC, Gorla MC, de Lemos AP, et al. The current situation of meningococcaldisease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations. Vaccine. 2015 Nov 27;33(48):6529\u201336.","DOI":"10.1016\/j.vaccine.2015.10.055"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, et al. Effect of a quadrivalent meningococcal ACWY glycoconjugateor a serogroup B meningococcalvaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinicaltrial. The Lancet. 2014 Dec 19; 384(9960):2123\u201331.","DOI":"10.1016\/S0140-6736(14)60842-4"},{"key":"ref18","unstructured":"18. Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Mar 22;62(RR-2):1\u201328."}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"es","link":[{"URL":"http:\/\/iris.paho.org\/xmlui\/bitstream\/handle\/123456789\/34359\/v41e1182017.pdf?sequence=5&isAllowed=y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T18:22:03Z","timestamp":1572632523000},"score":1,"resource":{"primary":{"URL":"http:\/\/iris.paho.org\/xmlui\/handle\/123456789\/34359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":18,"alternative-id":["RPSP.2017.118"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2017.118","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,20]]}}}